• Aubry-Damon H, Soussy CJ & Courvalin P (1998) Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 42: 25902594.
  • Besier S, Ludwig A, Brade V & Wichelhaus TA (2005) Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus. Antimicrob Agents Chemother 49: 14261431.
  • Bjorkman J, Nagaev I, Berg OG, Hughes D & Andersson DI (2000) Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287: 14791482.
  • Blondeau JM, Zhao X, Hansen G & Drlica K (2001) Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 45: 433438.
  • Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2006. (15 October 2006 date last accessed).
  • Denamur E, Bonacorsi S, Giraud A et al. (2002) High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol 184: 605609.
  • Denamur E, Tenaillon O, Deschamps C, Skurnik D, Ronco E, Gaillard JL, Picard B, Branger C & Matic I (2005) Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli. Genetics 171: 825827.
  • LeClerc JE, Li B, Payne WL & Cebula TA (1996) High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274: 12081211.
  • Lew DP & Waldvogel FA (1997) Osteomyelitis. N Engl J Med 336: 9991007.
  • Marti TM, Kunz C & Fleck O (2002) DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 191: 2841.
  • Morosini MI, Baquero MR, Sanchez-Romero JM, Negri MC, Galan JC, Del Campo R, Perez-Diaz JC & Baquero F (2003) Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob Agents Chemother 47: 14641467.
  • Oliver A, Canton R, Campo P, Baquero F & Blazquez J (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288: 12511254.
  • O'Neill AJ & Chopra I (2003) Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 47: 14841485; author reply 1485.
  • O'Reilly T & Mader JT (1999) Rat model of bacterial osteomyelitis of the tibia. Handbook of Animal Models of Infection (ZakO & SandeM, eds), pp. 561575. Academic Press, San Diego, CA.
  • Picard B, Duriez P, Gouriou S, Matic I, Denamur E & Taddei F (2001) Mutator natural Escherichia coli isolates have an unusual virulence phenotype. Infect Immun 69: 914.
  • Proctor RA, Von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M & Peters G (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4: 295305.
  • Prunier AL & Leclercq R (2005) Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus. J Bacteriol 187: 34553464.
  • Prunier AL, Malbruny B, Laurans M, Brouard J, Duhamel JF & Leclercq R (2003) High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 187: 17091716.
  • Richardson AR, Yu Z, Popovic T & Stojiljkovic I (2002) Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci USA 99: 61036107.
  • Schaaff F, Bierbaum G, Baumert N, Bartmann P & Sahl HG (2003) Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int J Med Microbiol 293: 427435.
  • Schmitz FJ, Fluit AC, Brisse S, Verhoef J, Kohrer K & Milatovic D (1999) Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol Med Microbiol 26: 281287.
  • Taddei F, Radman M, Maynard-Smith J, Toupance B, Gouyon P H & Godelle B (1997) Role of mutator alleles in adaptive evolution. Nature 387: 700702.
  • Trong HN, Prunier AL & Leclercq R (2005) Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 49: 20982101.
  • Watson ME Jr, Burns JL & Smith AL (2004) Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology 150: 29472958.